المؤلفون: B. Stollenwerk, K. Adachi, Shravanthi R. Gandra, Michael R. McClung, Kiyoshi Tanaka, H. Hagino, S. Silverman, M. Charokopou, B. Johnson

المصدر: Osteoporosis International. 32:2011-2021

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Cost effectiveness, Endocrinology, Diabetes and Metabolism, Osteoporosis, Romosozumab, 030209 endocrinology & metabolism, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Teriparatide, health care economics and organizations, romosozumab, teriparatide, Bone mineral, cost effectiveness, business.industry, Incidence (epidemiology), medicine.disease, osteoporosis, Relative risk, Cohort, 030101 anatomy & morphology, markov model, bone mineral density, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c7096ae651f3ad13239f8cea994fb1Test
https://doi.org/10.1007/s00198-021-05927-1Test

المؤلفون: J C Forfar, Lorenz C. Hofbauer, Bente L. Langdahl

المصدر: Langdahl, B L, Hofbauer, L C & Forfar, J C 2021, ' Cardiovascular Safety and Sclerostin Inhibition ', The Journal of clinical endocrinology and metabolism, vol. 106, no. 7, pp. 1845-1853 . https://doi.org/10.1210/clinem/dgab193Test

مصطلحات موضوعية: 0301 basic medicine, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Osteoporosis, sclerostin, Cardiovascular System, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Bone Density, Osteogenesis, Osteoporosis, Postmenopausal, Bone Density Conservation Agents, biology, Antibodies, Monoclonal, Middle Aged, medicine.anatomical_structure, Cardiovascular Diseases, RANKL, Female, Risk, medicine.medical_specialty, Romosozumab, 030209 endocrinology & metabolism, 03 medical and health sciences, cardiovascular safety, Osteoclast, Internal medicine, Product Surveillance, Postmarketing, medicine, Humans, Adverse effect, Adaptor Proteins, Signal Transducing, Proportional Hazards Models, romosozumab, business.industry, Biochemistry (medical), medicine.disease, osteoporosis, Clinical trial, 030104 developmental biology, Clinical Trials, Phase III as Topic, chemistry, Heart Disease Risk Factors, Relative risk, biology.protein, Sclerostin, business, Osteoporotic Fractures

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735a36ada85530b408b68cbf207c2a06Test
https://doi.org/10.1210/clinem/dgab193Test

المؤلفون: Bin Lu, Yan Li, Haobo Jia, Shan Zhu, Tian Aixian, Jianxiong Ma, Xinlong Ma

المصدر: Orthopaedic Surgery
Orthopaedic Surgery, Vol 13, Iss 7, Pp 1941-1950 (2021)

مصطلحات موضوعية: medicine.medical_specialty, Romosozumab, Review Article, Cochrane Library, law.invention, Postmenopausal osteoporosis, Randomized controlled trial, law, Bone Density, Internal medicine, Teriparatide, medicine, Humans, Orthopedics and Sports Medicine, Adverse effect, Review Articles, Osteoporosis, Postmenopausal, Femoral neck, Randomized Controlled Trials as Topic, Orthopedic surgery, Bone Density Conservation Agents, business.industry, Incidence (epidemiology), Antibodies, Monoclonal, medicine.anatomical_structure, Meta-analysis, Randomized controlled trials, Systematic review, Surgery, business, RD701-811, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::136403ac4b2e2ab618281ebd08c62e79Test
http://europepmc.org/articles/PMC8528978Test

المؤلفون: Takashi Sakai, Norihiro Nishida, Kiminori Yukata, Yuji Nagao, Atsushi Mihara, Ryuta Iwanaga, Kenzo Fujii, Toshihiro Seki

المصدر: World Journal of Orthopedics

مصطلحات موضوعية: medicine.medical_specialty, animal structures, Sclerostin antibody, Osteoporosis, Romosozumab, Fracture healing, Bone healing, Bone morphogenetic protein, Bone resorption, chemistry.chemical_compound, Internal medicine, Canonical Wnt-β-catenin pathway, Medicine, Orthopedics and Sports Medicine, Femur, Bone mineral, business.industry, fungi, Minireviews, medicine.disease, body regions, Endocrinology, chemistry, Sclerostin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a973dd3ec4482bf5201d086aca5ae0Test
https://doi.org/10.5312/wjo.v12.i9.651Test

المؤلفون: Willem F. Lems, Hennie G. Raterman, Laura P. B. Elbers

المصدر: Drugs
Elbers, L P B, Raterman, H G & Lems, W F 2021, ' Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review ', Drugs, vol. 81, no. 14, pp. 1645-1655 . https://doi.org/10.1007/s40265-021-01587-xTest

مصطلحات موضوعية: medicine.medical_specialty, Bone Density Conservation Agents, business.industry, Osteoporosis, Romosozumab, Review Article, medicine.disease, Bone remodeling, Discontinuation, Denosumab, Zoledronic acid, medicine.anatomical_structure, Bone Density, Internal medicine, medicine, Teriparatide, Humans, Pharmacology (medical), Bone Remodeling, business, Osteoporotic Fractures, Randomized Controlled Trials as Topic, medicine.drug, Femoral neck

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a84808e5828eb1c382c5249746ced5Test
https://doi.org/10.1007/s40265-021-01587-xTest

المؤلفون: J Sachin, J. N. Sharma, Siddhartha Dutta, Shoban Babu Varthya, Tarun Kumar, Sameer Khasbage, Surjit Singh

المصدر: Osteoporosis International. 33:1-12

مصطلحات موضوعية: Bone mineral, medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Osteoporosis, Romosozumab, medicine.disease, Rheumatology, medicine.anatomical_structure, Meta-analysis, Internal medicine, Orthopedic surgery, medicine, Adverse effect, business, Femoral neck

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::24f52b7848f04ce9207c617dfceb76d4Test
https://doi.org/10.1007/s00198-021-06095-yTest

المؤلفون: S Palacios

المصدر: Climacteric. 25:43-49

مصطلحات موضوعية: medicine.medical_specialty, Abaloparatide, Osteoporosis, Romosozumab, Anabolic Agents, Bone Density, Weight loss, Teriparatide, Internal medicine, medicine, Vitamin D and neurology, Humans, Osteoporosis, Postmenopausal, Bone Density Conservation Agents, Diphosphonates, business.industry, Obstetrics and Gynecology, General Medicine, medicine.disease, Denosumab, Quality of Life, Female, medicine.symptom, business, Osteoporotic Fractures, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ce69b2576bf2491c7dbb588bb0c000Test
https://doi.org/10.1080/13697137.2021.1951697Test

المؤلفون: Jacqueline So, Chi Chiu Mok

المصدر: Journal of Clinical Rheumatology and Immunology, Vol 20, Iss 2, Pp 71-79 (2020)

مصطلحات موضوعية: lcsh:Immunologic diseases. Allergy, 0301 basic medicine, corticosteroid, medicine.medical_specialty, medicine.drug_class, Osteoporosis, Romosozumab, 030209 endocrinology & metabolism, Bone remodeling, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Teriparatide, Medicine, In patient, romosozumab, teriparatide, business.industry, denosumab, glucocorticoid-induced osteoporosis, medicine.disease, 030104 developmental biology, Denosumab, Endocrinology, fracture, Corticosteroid, lcsh:RC581-607, business, Glucocorticoid, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2424305e1ac73c475c553ddbd6aa672bTest
https://doi.org/10.1142/s2661341720300074Test

المؤلفون: Masaaki Inaba, Shinsuke Yamada, Yoshiteru Ohno, Motohiko Sato, Masanori Emoto, Yoshihiro Tsujimoto

المصدر: Journal of Bone and Mineral Metabolism. 39:1082-1090

مصطلحات موضوعية: Vitamin, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Osteoporosis, Romosozumab, Gastroenterology, chemistry.chemical_compound, Endocrinology, Japan, Bone Density, Renal Dialysis, Internal medicine, medicine, Humans, Orthopedics and Sports Medicine, Dosing, Femoral neck, Bone mineral, Bone Density Conservation Agents, business.industry, Antibodies, Monoclonal, General Medicine, medicine.disease, medicine.anatomical_structure, chemistry, Orthopedic surgery, Hemodialysis, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e4f80846720e1b01d767178682bbf4Test
https://doi.org/10.1007/s00774-021-01253-yTest

المؤلفون: Sara Jane Cromer, Kristin M. D’Silva, Joan Landon, Elaine W. Yu, Rishi J. Desai, Seoyoung C. Kim

المصدر: J Gen Intern Med

مصطلحات موضوعية: Male, Pediatrics, medicine.medical_specialty, Abaloparatide, Osteoporosis, Romosozumab, Zoledronic Acid, 01 natural sciences, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Internal Medicine, medicine, Humans, 030212 general & internal medicine, 0101 mathematics, Medical prescription, Osteoporosis, Postmenopausal, Aged, Original Research, Alendronate, Bone Density Conservation Agents, business.industry, 010102 general mathematics, Middle Aged, medicine.disease, Denosumab, Zoledronic acid, Cohort, Female, business, Osteoporotic Fractures, Cohort study, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5653fe60c32a2dfe3b4a1c59121f51Test
https://doi.org/10.1007/s11606-021-06938-8Test